The University of Chicago Header Logo

Connection

David Grinblatt to Melphalan

Back to Details
This is a "connection" page, showing publications David Grinblatt has written about Melphalan.
David Grinblatt
Connection Strength
0.028
Melphalan
  1. Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck. Invest New Drugs. 1994; 12(1):45-7.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.